Niconex Medical Ltd | E-mail:info@niconmedical.com | Phone: +357 22 250804 | Office Hours: M-Fr 09:00-18:00

Niconex Medical Ltd – Regulatory Affairs and Pharmacovigilance Consulting Services

Niconex Medical is a new company providing expertise in local regulatory affairs, pharmacovigilance and medical affairs. The company understands clients’ requirements and engages to ensure high-quality results are delivered in a timely manner to maintain product safety and updated dossiers.


At Niconex Medical we provide local Regulatory Affairs and Pharmacovigilance services to support pharmaceutical companies in the registration and maintenance of medicinal products and medical devices in the Republic of Cyprus. In line with safety obligations, Niconex Medical offers local Pharmacovigilance representation for constant monitoring and safety reporting. Our consulting services include regulatory intelligence available on a regular basis or per request to support in advance planning and preparation aligned with National Competent Authority (NCA) requirements.

Local Regulatory Affairs in compliance with requirements to achieve high-quality results within stringent timelines.

Local Regulatory Affairs Affiliate Service

Niconex Medical acts as local Regulatory Affairs contact for all regulatory matters pertaining to partners’ products including preparation of local dossier, submission of applications e.g. new Marketing Authorization applications, Variations, Renewals, Responses to Questions, Post-Approval commitments e.t.c., align / validate local Product Information, translations, quality control of artworks, any follow-up actions or communications with local Health Authorities with regards to submissions, deficiencies and other national requests. Niconex Medical can support with regulatory intelligence to assist partners in planning and preparing in advance according to local regulations.

Read More

Local Pharmacovigilance services to constantly monitor and maintain safe products in accordance with regulations.

Local Pharmacovigilance Affiliate Service

Provision of local 24/7 responsible person for Pharmacovigilance in line with local requirements to monitor product safety at national level and maintain reporting in timely manner according to required deadlines. Niconex Medical also supports with submission of safety reports, Dear Healthcare Provider (DHCP) letter preparation, submission for approval and dissemination to concerned local parties. In addition, we provide quality control and approval of Educational and / or Promotional Material according to national requirements. If required, we additionally support with scientific and medical HCP communications or visits as partial fulfillment of local Medical Affairs or Medical Science Liaison (MSL) service.

Read More

Support with periodic queries or tasks related to Regulatory Affairs, Pharmacovigilance, Medical Affairs and Market Access.

Consulting Services

Individual services are provided to additionally support periodic requirements of local regulatory intelligence, local NCA fees information, pricing approvals, sales submissions, support with periodic reports, clinical / non-clinical overviews or any other ad hoc individual services e.g. per request DHCP letters, additional document submissions or regulatory reviews and translation services of product texts, additional per request communications with local Authorities.

Read More

Go to article: Home | Trust In Big PharmaGo to article: EditorialGo to article: NSFGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: FreudenbergGo to article: The Pharma Industry BriefingGo to article: Fisher Clinical Services Company InsightGo to article: Fisher Clinical ServicesGo to article: The People vs Big Pharma: tackling the industry’s trust issuesGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: Humira: the highs and lows of the world’s most successful drug Go to article: Wilhelm Haselmeier GmbH & Co KG Company InsightGo to article: Wilhelm Haselmeier GmbH & Co. KGGo to article: Gene therapy: talking smart solutions with Bluebird BioGo to article: Moehs Iberica Company InsightGo to article: Moehs Iberica SLGo to article: A research headache: improving the understanding of chronic migraine Go to article: SensitechGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Philanthropy in pharma: a look inside the ISPE FoundationGo to article: DelSiTechGo to article: Novel Oral Therapies Are An Unmet Need For Ulcerative ColitisGo to article: PhoenixGo to article: FDA removes key barrier to US biosimilar developmentGo to article: Nipro PharmaPackagingGo to article: Pfizer price hikes: do rare cancer drugs warrant higher prices?Go to article: AlpexGo to article: Head-to-head: competing for the most effective psoriasis drugGo to article: Mecmesin Company InsightGo to article: MecmesinGo to article: Takeda to seek label expansion for Ninlaro in multiple myelomaGo to article: Capsugel Company InsightGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Epilepsy: Zogenix’s ZX008 set for showdown with GW Pharma’s EpidiolexGo to article: EcocoolGo to article: Abiogen PharmaGo to article: Illegal online pharmacies: how endemic are they?Go to article: Global Freight Solutions LtdGo to article: The boom in medical cannabis research is set to continueGo to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Population boom will boost acute stroke market, particularly in ChinaGo to article: Pall BiotechGo to article: Cryo StoreGo to article: Watch Alibaba instead of Amazon in healthcareGo to article: WIKA - Disaster preventionGo to article: AstraZeneca’s Lynparza maintains lead in PARP inhibitor raceGo to article: G.F.Go to article: Erdmann Design SwitzerlandGo to article: CMV presents a serious concern in HIV+ personsGo to article: BEA TechnologiesGo to article: BaxterGo to article: bDMARD therapy: adherence in the first year is key to successGo to article: Pharma Support Services Ltd Company InsightGo to article: Pharma Support Services LtdGo to article: End the struggle: pathways to HEAL the opioid crisisGo to article: LaudaGo to article: AbbVie poised to overtake Gilead as hepatitis C leaderGo to article: ILC Dover IncGo to article: ViiV results show the importance of INIs to future HIV treatmentGo to article: PfanstiehlGo to article: Novartis acquires rights to atopic dermatitis candidate MOR106Go to article: Niconex Medical LtdGo to article: EventsGo to article: Next issue